As one of the largest healthcare tech deals in 2020, Thermo Fisher is buying coronavirus diagnostics company Qiagen NV for €9 billion. QIAGEN is considered a leading global provider of molecular diagnostics and sample preparation technologies. The deal has been approved by the boards of directors at both companies as well as the managing board of QIAGEN.
{iframe}https://pulse2.com/thermo-fisher-acquiring-qiagen-for-e9-billion-details-about-the-deal-you-should-know/{/iframe}